@FierceMedDev: ICYMI yesterday: Brain tumor treatment device gets early trial halt for efficacy as a combo with chemo. Story | Follow @FierceMedDev
@EmilyWFierce: Shaq is back for $SNY's latest marketing campaign. Release | Follow @EmilyWFierce
> Corpak MedSystems, a medical device company focused on enteral access technologies, acquired France-based Maxter Catheters, developer of disposable medical devices, for an undisclosed amount. Release
> An academic points out that there is no FDA approval or published data supporting claims that wearable baby monitors prevent sudden infant death syndrome (SIDS). Release
> South Korean company creates Arki, a wristband that uses arm swing patterns to detect bad posture and alerts wearer to adjust their posture. Watch
> CoorsTek Medical acquired Italian device manufacturer Nanosurfaces Industries for an undisclosed amount. Release
Biotech News
@FierceBiotech: Agios offers another glimpse of 'exciting' early data for a leukemia drug. Report | Follow @FierceBiotech
@JohnCFierce: Lots of discussion about this one -- Average cost of drug R&D? Try $2.9B on for size. Editor's Corner | Follow @JohnCFierce
@DamianFierce: Knight Therapeutics found a buyer for its FDA priority review voucher, selling it to $GILD for $125M. Release | Follow @DamianFierce
> Sanofi's shortlist of CEO candidates so far has a distinct French accent. Item
> Shire orders 500 staffers to move to Boston-area biotech 'Mecca.' Report
> Bind heralds hope for its nanotech cancer drug after mixed Phase II. Story
> Go-go execs at Gilead nab an FDA priority review voucher for $125M. News
Pharma News
@FiercePharma: Ranbaxy fights FDA for killing its approval to make generic Nexium. FiercePharmaManufacturing story | Follow @FiercePharma
@CarlyHFierce: AirFluSal Forspiro won approval in my two favorite countries, Ireland & Czech Republic, which is inconsequential to me but fun nonetheless. | Follow @CarlyHFierce
> Novartis seeks tech partners for brave new beyond-the-pill world. More
> Solo Shire moves 500 to Boston as it pushes ahead with reorg. Story
> NICE asks Novartis to pony up more information on Xolair for hives. Report
Drug Delivery News
> Cynapsus releases clinical trial data about its sublingual thin-film strip for Parkinson's. Item
> Catalent buys particle engineering outfit Micron Technologies. News
> RNAi masking technique allows more efficient delivery. Story
> Medical marijuana company licenses RapidMist device for buccal delivery. Report
> NSF funds further research into only FDA-cleared catheter for rectal delivery. Article
Diagnostics News
> Precision Therapeutics ropes in $60M for corporate overhaul. More
> Cepheid snags $3.3M to roll out rapid Ebola test. Report
> Roche nabs FDA clearance for quick strep test. News
> Illumina, Sequenta partner up on next-gen cancer diagnostic. Article
> Enterome teams up with AbbVie to create molecular Dx for Crohn's disease. Item
Pharma Marketing News
> Payers' hep C delay tactics work: Coverage hurdles may be dampening Harvoni script growth. Article
> How to prep for a 'megablockbuster' launch? Novartis lines up cost-savings data. Report
> Valeant and Allergan's wining-and-dining shows docs still hold the script reins. More
> Painkiller marketing secrets? Check Chicago's unredacted suit against Endo, Purdue, Cephalon, et al. Story
> Sanofi tags newly OK'd MS drug Lemtrada at $158K, ready to tout head-to-head Rebif data. Article